Endoscopic Intragastric Injection of Botulinum Toxin A in Obese Patients Accelerates Weight Loss after Bariatric Surgery: Follow-Up of a Randomised Controlled Trial (IntraTox Study).

Sánchez-Torralvo Francisco JoséLuis Vázquez-PedreñoMontserrat Gonzalo-MarínMaría José Tapia GuerreroFuensanta LimaEduardo Garcia-FuentesPilar GarcíaJavier Moreno-RuizAlberto Rodríguez-CañeteSergio ValdésGabriel Olveira Fuster

Published in: Journal of clinical medicine (2022)

intragastric injection of BT-A is effective to achieve significant weight loss, especially in extreme obesity. Its use before bariatric surgery enhances perioperative weight loss.

Keyphrases

weight loss
bariatric surgery
obese patients
roux en y gastric bypass
botulinum toxin
gastric bypass
ultrasound guided
weight gain
climate change
patients undergoing
physical activity
acute kidney injury
adipose tissue
insulin resistance
body mass index
skeletal muscle